Empowered Patient Podcast

Shaun Bagai, CEO of RenovoRx,  has designed a drug-delivery platform to treat hard-to-reach chemo-resistant tumors such as pancreatic cancer by delivering chemotherapy directly to the tumor site. The RenovoCath device increases the drug concentration in the tumor while significantly reducing systemic toxicities and side effects. The technology is not intended to replace the traditional approach using systemic chemotherapy and radiation, but to achieve better results in tumors with low blood supply that prevent drugs from reaching their target in sufficient concentrations. Shaun explains, "Generally, when we think about oncology therapies, it's really trying to balance the detriment to the patients with the toxicities and hopefully keep the tumor at bay or kill the tumor such that patients live longer. And unfortunately, we often forget about the patient and hyper-focus on the disease. And the challenge we've taken on is, can we take both into account and actually treat both the patient and the disease by lim